JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dorigo, P.
Right arrow Articles by Da Settimo, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dorigo, P.
Right arrow Articles by Da Settimo, F.

Vol. 295, Issue 3, 994-1004, December 2000

Pharmacological Characterization of a New Ca2+ Sensitizer1

Paola Dorigo, Maura Floreani, Giovanni Santostasi, Ildebrando Maragno, Daniela Danieli-Betto, Elena Germinario, Sebastiano Marciani Magno, Gianpaolo Primofiore, Anna Maria Marini and Federico Da Settimo

Departments of Pharmacology and Anesthesiology (P.D., M.F., G.S., I.M.), Human Anatomy and Physiology (D.D.B., E.G.), and Pharmaceutical Sciences (S.M.M.), University of Padova, Padova, Italy; and Department of Pharmaceutical Sciences, University of Pisa, Pisa, Italy (G.P., A.M.M., F.D.S.)

The benzimidazole molecule was modified to synthesize a Ca2+ sensitizer devoid of additional effects associated with Ca2+ overload. Newly synthesized compounds, termed 1, 2, 3, 4, and 5, were evaluated in spontaneously beating and electrically driven atria from reserpine-treated guinea pigs. Compound 3 resulted as the most effective positive inotropic agent, and experiments were performed to study its mechanism of action. In spontaneously beating atria, the inotropic effect of 3 was concentration-dependent (3.0 µM-0.3 mM). Compound 3 was more potent and more active than the structurally related Ca2+ sensitizers sulmazole and caffeine, but unlike them it did not increase the heart rate. In electrically driven atria, the inotropic activity of 3 was well preserved and it was not inhibited by propranolol, prazosin, ranitidine, pyrilamine, carbachol, adenosine deaminase, or ruthenium red. At high concentrations (0.1-1.0 mM) 3 inhibited phosphodiesterase-III, whereas it did not affect Na+/K+-ATPase, sarcolemmal Ca2+-ATPase, Na+/Ca2+ exchange carrier, or sarcoplasmic reticulum Ca2+ pump activities of guinea pig heart. In skinned fibers obtained from guinea pig papillary muscle and skeletal soleus muscle, compound 3 (0.1 mM, 1 mM) shifted the pCa/tension relation curve to the left, with no effect on maximal tension and no signs of toxicity. Compound 3 did not influence the basal or raised tone of guinea pig isolated aorta rings, whose cells do not contain the contractile protein troponin. The present results indicate that the inotropic effect of compound 3 seems to be primarily sustained by sensitization of the contractile proteins to Ca2+.


1 This study was supported by a grant from Ministero dell'Università e della Ricerca Scientifica e Tecnologica, Italy (MURST 40%), and by a grant from Ministero dell'Università e della Ricerca Scientifica e Tecnologica, Italy (cofinanziamento 9806197882-002 to P.D.).


0022-3565/00/2953-0994$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics






Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics.